Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

ACOR.Q

Acorda Therapeutics (ACOR.Q) announced today that it has entered into a distribution and supply agreement with Esteve Pharmaceuticals to commercialize INBRIJA® 33 mg in Spain.     “We are…